Board Meeting9 Nov 2026, 04:09 pm
Vanta Bioscience Ltd Board Meeting on Nov 13 to Approve Financial Results
AI Summary
Vanta Bioscience Ltd has announced that its Board of Directors will convene on November 13, 2026, to consider and approve the standalone and consolidated unaudited financial results for the half-year ended September 30, 2026. The meeting will also include a review of the Limited Review Report from the statutory auditors. In line with insider trading policies, the trading window for designated persons remains closed from October 1, 2026, to November 15, 2026.
Key Highlights
- Board meeting scheduled for November 13, 2026.
- Approval of unaudited financial results for H1 FY27.
- Limited Review Report by statutory auditors to be noted.
- Trading window closure for designated persons until November 15, 2026.
Price Impact
More from VANTABIO